Rangers’ Roster Shake-Up: Josh Jung Hits IL, Josh Smith Steps Up

The Texas Rangers have delivered a roster update that’s equal parts expected and unsettling: star third baseman Josh Jung is heading to the injured list with a calf strain, while utility infielder Josh Smith gets the call from Triple-A Round Rock. The move, announced just as the trade deadline looms, underscores the Rangers’ precarious position as they balance contender ambitions with injury setbacks.

A Setback at the Worst Time

Jung, a cornerstone of Texas’ lineup, has been a consistent offensive force, slashing .280/.340/.480 this season with 15 home runs and 50 RBIs. His absence leaves a significant void in both power and defensive stability at the hot corner. The calf strain, while not yet deemed severe, arrives at a critical juncture. With the July 31 trade deadline fast approaching, the Rangers now face a dilemma: do they pursue a short-term replacement, or trust their internal options to hold the line?

Manager Bruce Bochy has been tight-lipped about Jung’s timeline, but early reports suggest he could miss at least 2–3 weeks. For a team clinging to a playoff spot in a hyper-competitive AL West, every game matters. The injury also complicates potential trade discussions, as rival clubs may see Texas as more desperate to add infield depth.

Josh Smith: The Next Man Up

Enter Josh Smith, the 26-year-old switch-hitter who’s spent most of 2026 refining his game in Round Rock. Smith, known for his versatility, has logged time at second base, shortstop, and third base this season, posting a respectable .275/.350/.420 line in the minors. While he lacks Jung’s offensive ceiling, his defensive flexibility and left-handed bat could provide a spark.

“Josh [Smith] has been working hard on his consistency,” Bochy noted in a post-game presser. “He’s a guy who can play multiple positions and give us quality at-bats. We’re confident he’ll step up.”

What This Means for the Trade Deadline

The Rangers’ front office, led by Chris Young, now faces a high-stakes chess match. Do they:

• Stand pat and rely on Smith, Ezequiel Duran, or other internal options to cover third base?
• Target a rental bat like the White Sox’s Yoán Moncada or the Reds’ Jonathan India to bridge the gap?
• Swing for a bigger name (e.g., the Orioles’ Gunnar Henderson in a blockbuster) to solidify the infield for years to come?

Each path carries risks. Trading for a rental could deplete the farm system further, while overpaying for a long-term piece might backfire if Jung returns at full strength. Meanwhile, standing pat risks falling behind in a division where the Astros and Mariners are surging.

The Bigger Picture: Depth and Resilience

Injuries are an inevitable part of baseball, but the Rangers’ ability to weather this storm could define their season. The team has already navigated absences from Corey Seager and Adolis García this year, proving their resilience. Now, with Jung sidelined, the depth of their minor-league pipeline—and their front office’s creativity—will be tested like never before.

For fans, the message is clear: This is a pivotal moment. The Rangers can either treat Jung’s injury as a minor hiccup or a catalyst for bold moves. Either way, the next few weeks will reveal just how serious Texas is about returning to the World Series.

The Rangers’ decision to place Jung on the IL and recall Smith is more than a transaction—it’s a litmus test. Can a team built on power and pitching adapt when its stars are sidelined? As the trade deadline nears, all eyes will be on Arlington to see if Texas doubles down on its championship aspirations or plays it safe. One thing’s certain: This summer just got a lot more interesting.

Source: mlbtraderumors.com via Google News